jobs.jnj.com/en/jobs/

✕

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.

Share

COVID-19 Statements

MEDIA STATEMENT

May 05, 2022

Johnson & Johnson Updates U.S. COVID-19 Vaccine Fact Sheet
Media Statement

April 04, 2022

World Health Organization Updated Emergency Use Listing Recommends Johnson & Johnson COVID-19 Vaccine for Booster Use
MEDIA STATEMENT

December 16, 2021

Johnson & Johnson Statement on its COVID-19 Vaccine Following CDC ACIP Meeting
December 16, 2021

Penny Heaton, M.D., Global Therapeutic Area Head, Vaccines, Janssen Research & Development, LLC
Media Statement

November 30, 2021

Johnson & Johnson Discussions to License its COVID-19 Vaccine to Aspen Reach Advanced Stage
Media Statement

November 29, 2021

Johnson & Johnson to Evaluate Its COVID-19 Vaccine Against New Omicron COVID-19 Variant
Media Statement

November 22, 2021

Almost 100 Million Doses of Johnson & Johnson COVID-19 Vaccine to be Donated to Lower Income Countries Through COVAX
Media Statement

October 18, 2021

17 Million Doses of Johnson & Johnson COVID-19 Vaccine to be Donated to African Union Countries
MEDIA STATEMENT

August 18, 2021

Statement on Boosting with the Johnson & Johnson COVID-19 Vaccine
Media Statement

July 28, 2021

Johnson & Johnson Statement on U.S. FDA Approval of Shelf Life Extension for Company’s COVID-19 Vaccine
Our Company

July 12, 2021

Johnson & Johnson Statement on COVID-19 Vaccine (7/12)
Our Company

June 11, 2021

Johnson & Johnson Statement on Supply of its Single-shot COVID-19 Vaccine
Our Company

April 23, 2021

Johnson & Johnson Statement on April 23 CDC Advisory Committee Meeting on Company COVID-19 Vaccine
Our Company

April 21, 2021

Johnson & Johnson Statement on FDA Observations at Emergent BioSolutions (Updated 4/30)
Our Company

April 14, 2021

Johnson & Johnson Statement on CDC Advisory Committee Meeting on Company COVID-19 Vaccine
Our Company

April 13, 2021

Johnson & Johnson Statement on COVID-19 Vaccine (Updated)
Our Company

April 03, 2021

Johnson & Johnson Statement on U.S. COVID-19 Vaccine Manufacturing (Updated)
Our Company

March 31, 2021

Johnson & Johnson Statement on U.S. COVID-19 Vaccine Manufacturing
Our Company

March 17, 2021

Statement on the Interim SAGE Recommendation Supporting the Use of the Johnson & Johnson COVID-19 Vaccine
Our Company

March 02, 2021

Johnson & Johnson Statement on Collaboration with Merck
Our Company

September 23, 2020

Johnson & Johnson Business Continuity Statement (9/23)
Our Company

August 13, 2020

Discussions Progress Between Johnson & Johnson and the European Commission Regarding Company’s Investigational COVID-19 Vaccine
Our Company

April 24, 2020

Statement of Support on Access to New COVID-19 Tools
Our Company

March 02, 2020

Johnson & Johnson Statement following White House Meeting on the Coronavirus